Xenetic Biosciences, Inc.
XBIO· Nasdaq
XBIOXenetic Biosciences, Inc.
Filed Nov 14, 2014 · 10-Q · 45 days after period end · 0001193125-14-413225
| Metric | Q3 2014 | Q3 2013 |
|---|---|---|
| Net Income | -$3.18M | -$2.73M |
| EPS Diluted | -$0.02 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 14, 2014 · 45 d after period end
